LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 1 of total 1

Search options

Article ; Online: Comparison of the immunogenicity and protective efficacy of ACAM2000, MVA, and vectored subunit vaccines for Mpox in rhesus macaques.

Jacob-Dolan, Catherine / Ty, Darren / Hope, David / McMahan, Katherine / Liu, Jinyan / Powers, Olivia C / Cotter, Catherine A / Sciacca, Michela / Wu, Cindy / Borducchi, Erica / Bouffard, Emily / Richter, Hannah / Velasco, Jason / Teow, Elyse / Boursiquot, Mona / Cook, Anthony / Feliciano, Karen / Yalley-Ogunro, Jake / Seaman, Michael S /
Pessiant, Laurent / Lewis, Mark G / Andersen, Hanne / Moss, Bernard / Barouch, Dan H

Science translational medicine

2024  Volume 16, Issue 740, Page(s) eadl4317

Abstract: The 2022-2023 mpox outbreak triggered vaccination efforts using smallpox vaccines that were approved for mpox, including modified vaccinia Ankara (MVA; JYNNEOS), which is a safer alternative to live replicating vaccinia virus (ACAM2000). Here, we compare ...

Abstract The 2022-2023 mpox outbreak triggered vaccination efforts using smallpox vaccines that were approved for mpox, including modified vaccinia Ankara (MVA; JYNNEOS), which is a safer alternative to live replicating vaccinia virus (ACAM2000). Here, we compare the immunogenicity and protective efficacy of JYNNEOS by the subcutaneous or intradermal routes, ACAM2000 by the percutaneous route, and subunit Ad35 vector-based L1R/B5R or L1R/B5R/A27L/A33R vaccines by the intramuscular route in rhesus macaques. All vaccines provided robust protection against high-dose intravenous mpox virus challenge with the current outbreak strain, with ACAM2000 providing near complete protection and JYNNEOS and Ad35 vaccines providing robust but incomplete protection. Protection correlated with neutralizing antibody responses as well as L1R/M1R- and B5R/B6R-specific binding antibody responses, although additional immune responses likely also contributed to protection. This study demonstrates the protective efficacy of multiple vaccine platforms against mpox virus challenge, including both current clinical vaccines and vectored subunit vaccines.
MeSH term(s) Animals ; Vaccinia virus/genetics ; Macaca mulatta ; Mpox (monkeypox) ; Antibodies, Viral ; Smallpox Vaccine ; Vaccines, Subunit
Chemical Substances ACAM2000 ; Antibodies, Viral ; Smallpox Vaccine ; Vaccines, Subunit
Language English
Publishing date 2024-03-27
Publishing country United States
Document type Journal Article
ZDB-ID 2518854-9
ISSN 1946-6242 ; 1946-6234
ISSN (online) 1946-6242
ISSN 1946-6234
DOI 10.1126/scitranslmed.adl4317
Shelf mark
Zs.A 6941: Show issues Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)
Database MEDical Literature Analysis and Retrieval System OnLINE

More links

Kategorien

To top